APO Research

APO RESEARCH · REPORT

Oral Veterinary Pain Management Drugs

Selected research

Market Outlook & Growth Opportunities

Global Oral Veterinary Pain Management Drugs Market Outlook and Growth Opportunities 2026

Market perspective

The global Oral Veterinary Pain Management Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Veterinary Pain Management Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Veterinary Pain Management Drugs market include Zoetis, Merck & Co, Medtronic, Lilly, Bayer Pharma AG, Baxter, Norbrook Laboratories, Halyard and Forest Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Oral Veterinary Pain Management Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Veterinary Pain Management Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Veterinary Pain Management Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Oral Veterinary Pain Management Drugs market.

Oral Veterinary Pain Management Drugs Segment by Company

Zoetis

Merck & Co

Medtronic

Lilly

Bayer Pharma AG

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Bostonscientific

Boehringer Ingelheim

Oral Veterinary Pain Management Drugs Segment by Type

Sedatives

Local Anesthetics

Nonsteroidal Anti-Inflammatory Drugs (NSIDs)

Opioids

α2-Adrenergic Agonists

Other

Oral Veterinary Pain Management Drugs Segment by Application

Veterinary Clinics

Veterinary Hospitals

For Retail

Others

Oral Veterinary Pain Management Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral Veterinary Pain Management Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Oral Veterinary Pain Management Drugs key companies, revenue, market share, and recent developments.

3. To split the Oral Veterinary Pain Management Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Oral Veterinary Pain Management Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Veterinary Pain Management Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Veterinary Pain Management Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Veterinary Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Veterinary Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Veterinary Pain Management Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Veterinary Pain Management Drugs industry.

Chapter 3: Detailed analysis of Oral Veterinary Pain Management Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Oral Veterinary Pain Management Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Oral Veterinary Pain Management Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Veterinary Pain Management Drugs Industry Trends Table 2. Oral Veterinary Pain Management Drugs Industry Drivers Table 3. Oral Veterinary Pain Management Drugs Industry Opportunities and Challenges Table 4. Oral Veterinary Pain Management Drugs Industry Restraints Table 5. Global Oral Veterinary Pain Management Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Veterinary Pain Management Drugs Revenue Share by Company (2021-2026) Table 7. Global Oral Veterinary Pain Management Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Oral Veterinary Pain Management Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Oral Veterinary Pain Management Drugs Company, Product Type & Application Table 10. Global Oral Veterinary Pain Management Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Oral Veterinary Pain Management Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sedatives Table 15. Significant Companies of Local Anesthetics Table 16. Significant Companies of Nonsteroidal Anti-Inflammatory Drugs (NSIDs) Table 17. Significant Companies of Opioids Table 18. Significant Companies of α2-Adrenergic Agonists Table 19. Significant Companies of Other Table 20. Global Oral Veterinary Pain Management Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Oral Veterinary Pain Management Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Oral Veterinary Pain Management Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Oral Veterinary Pain Management Drugs Sales Value Share by Type (2021-2026) Table 24. Global Oral Veterinary Pain Management Drugs Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Veterinary Clinics Table 26. Significant Companies of Veterinary Hospitals Table 27. Significant Companies of For Retail Table 28. Significant Companies of Others Table 29. Global Oral Veterinary Pain Management Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Oral Veterinary Pain Management Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Oral Veterinary Pain Management Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Oral Veterinary Pain Management Drugs Sales Value Share by Application (2021-2026) Table 33. Global Oral Veterinary Pain Management Drugs Sales Value Share by Application (2027-2032) Table 34. Global Oral Veterinary Pain Management Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Oral Veterinary Pain Management Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Oral Veterinary Pain Management Drugs Sales Value Share by Region (2021-2026) Table 37. Global Oral Veterinary Pain Management Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Oral Veterinary Pain Management Drugs Sales Value Share by Region (2027-2032) Table 39. Global Oral Veterinary Pain Management Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Oral Veterinary Pain Management Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Oral Veterinary Pain Management Drugs Sales Value Market Share by Country (2021-2026) Table 42. Global Oral Veterinary Pain Management Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Oral Veterinary Pain Management Drugs Sales Value Market Share by Country (2027-2032) Table 44. Zoetis Company Information Table 45. Zoetis Business Overview Table 46. Zoetis Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Zoetis Oral Veterinary Pain Management Drugs Product Portfolio Table 48. Zoetis Recent Development Table 49. Merck & Co Company Information Table 50. Merck & Co Business Overview Table 51. Merck & Co Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Merck & Co Oral Veterinary Pain Management Drugs Product Portfolio Table 53. Merck & Co Recent Development Table 54. Medtronic Company Information Table 55. Medtronic Business Overview Table 56. Medtronic Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Medtronic Oral Veterinary Pain Management Drugs Product Portfolio Table 58. Medtronic Recent Development Table 59. Lilly Company Information Table 60. Lilly Business Overview Table 61. Lilly Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Lilly Oral Veterinary Pain Management Drugs Product Portfolio Table 63. Lilly Recent Development Table 64. Bayer Pharma AG Company Information Table 65. Bayer Pharma AG Business Overview Table 66. Bayer Pharma AG Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bayer Pharma AG Oral Veterinary Pain Management Drugs Product Portfolio Table 68. Bayer Pharma AG Recent Development Table 69. Baxter Company Information Table 70. Baxter Business Overview Table 71. Baxter Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Baxter Oral Veterinary Pain Management Drugs Product Portfolio Table 73. Baxter Recent Development Table 74. Norbrook Laboratories Company Information Table 75. Norbrook Laboratories Business Overview Table 76. Norbrook Laboratories Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Norbrook Laboratories Oral Veterinary Pain Management Drugs Product Portfolio Table 78. Norbrook Laboratories Recent Development Table 79. Halyard Company Information Table 80. Halyard Business Overview Table 81. Halyard Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Halyard Oral Veterinary Pain Management Drugs Product Portfolio Table 83. Halyard Recent Development Table 84. Forest Laboratories Company Information Table 85. Forest Laboratories Business Overview Table 86. Forest Laboratories Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Forest Laboratories Oral Veterinary Pain Management Drugs Product Portfolio Table 88. Forest Laboratories Recent Development Table 89. Endo International Company Information Table 90. Endo International Business Overview Table 91. Endo International Oral Veterinary Pain Management Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Endo International Oral Veterinary Pain Management Drugs Product Portfolio Table 93. Endo International Recent Development Table 94. Elanco Company Information Table 95. Elanco Business Overview Table 96. Elanco Oral Veterinary Pain Management Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Elanco Oral Veterinary Pain Management Drugs Product Portfolio Table 98. Elanco Recent Development Table 99. Ceva Sante Animale Company Information Table 100. Ceva Sante Animale Business Overview Table 101. Ceva Sante Animale Oral Veterinary Pain Management Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Ceva Sante Animale Oral Veterinary Pain Management Drugs Product Portfolio Table 103. Ceva Sante Animale Recent Development Table 104. Bostonscientific Company Information Table 105. Bostonscientific Business Overview Table 106. Bostonscientific Oral Veterinary Pain Management Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Bostonscientific Oral Veterinary Pain Management Drugs Product Portfolio Table 108. Bostonscientific Recent Development Table 109. Boehringer Ingelheim Company Information Table 110. Boehringer Ingelheim Business Overview Table 111. Boehringer Ingelheim Oral Veterinary Pain Management Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Boehringer Ingelheim Oral Veterinary Pain Management Drugs Product Portfolio Table 113. Boehringer Ingelheim Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Oral Veterinary Pain Management Drugs Product Image Figure 2. Global Oral Veterinary Pain Management Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Veterinary Pain Management Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Veterinary Pain Management Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sedatives Image Figure 8. Local Anesthetics Image Figure 9. Nonsteroidal Anti-Inflammatory Drugs (NSIDs) Image Figure 10. Opioids Image Figure 11. α2-Adrenergic Agonists Image Figure 12. Other Image Figure 13. Global Oral Veterinary Pain Management Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Oral Veterinary Pain Management Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Veterinary Pain Management Drugs Sales Value Share by Type (2021-2032) Figure 16. Veterinary Clinics Image Figure 17. Veterinary Hospitals Image Figure 18. For Retail Image Figure 19. Others Image Figure 20. Global Oral Veterinary Pain Management Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Oral Veterinary Pain Management Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Oral Veterinary Pain Management Drugs Sales Value Share by Application (2021-2032) Figure 23. Global Oral Veterinary Pain Management Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Oral Veterinary Pain Management Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Oral Veterinary Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 26. North America Oral Veterinary Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Oral Veterinary Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Oral Veterinary Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Oral Veterinary Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Oral Veterinary Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Oral Veterinary Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. South America Oral Veterinary Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Oral Veterinary Pain Management Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Oral Veterinary Pain Management Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Sedatives
  • Local Anesthetics
  • Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
  • Opioids
  • α2-Adrenergic Agonists
  • Other
Applications
  • Veterinary Clinics
  • Veterinary Hospitals
  • For Retail
  • Others
Companies covered
  • Zoetis
  • Merck & Co
  • Medtronic
  • Lilly
  • Bayer Pharma AG
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Bostonscientific
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Veterinary Pain Management Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Veterinary Pain Management Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Oral Veterinary Pain Management Drugs Market Dynamics
  1. 2.1 Oral Veterinary Pain Management Drugs Industry Trends
  2. 2.2 Oral Veterinary Pain Management Drugs Industry Drivers
  3. 2.3 Oral Veterinary Pain Management Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Veterinary Pain Management Drugs Industry Restraints
3 Oral Veterinary Pain Management Drugs Market by Company
  1. 3.1 Global Oral Veterinary Pain Management Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Oral Veterinary Pain Management Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Oral Veterinary Pain Management Drugs Company Ranking (2024-2026)
  4. 3.4 Global Oral Veterinary Pain Management Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Oral Veterinary Pain Management Drugs Company Product Type and Application
  6. 3.6 Global Oral Veterinary Pain Management Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Oral Veterinary Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Oral Veterinary Pain Management Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Oral Veterinary Pain Management Drugs Market by Type
  1. 4.1 Oral Veterinary Pain Management Drugs Type Introduction
  2. 4.1.1 Sedatives
  3. 4.1.2 Local Anesthetics
  4. 4.1.3 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
  5. 4.1.4 Opioids
  6. 4.1.5 α2-Adrenergic Agonists
  7. 4.1.6 Other
  8. 4.2 Global Oral Veterinary Pain Management Drugs Sales Value by Type
  9. 4.2.1 Global Oral Veterinary Pain Management Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Oral Veterinary Pain Management Drugs Sales Value by Type (2021-2032)
  11. 4.2.3 Global Oral Veterinary Pain Management Drugs Sales Value Share by Type (2021-2032)
5 Oral Veterinary Pain Management Drugs Market by Application
  1. 5.1 Oral Veterinary Pain Management Drugs Application Introduction
  2. 5.1.1 Veterinary Clinics
  3. 5.1.2 Veterinary Hospitals
  4. 5.1.3 For Retail
  5. 5.1.4 Others
  6. 5.2 Global Oral Veterinary Pain Management Drugs Sales Value by Application
  7. 5.2.1 Global Oral Veterinary Pain Management Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oral Veterinary Pain Management Drugs Sales Value by Application (2021-2032)
  9. 5.2.3 Global Oral Veterinary Pain Management Drugs Sales Value Share by Application (2021-2032)
6 Oral Veterinary Pain Management Drugs Regional Value Analysis
  1. 6.1 Global Oral Veterinary Pain Management Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Veterinary Pain Management Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Oral Veterinary Pain Management Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Oral Veterinary Pain Management Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Veterinary Pain Management Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Oral Veterinary Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Oral Veterinary Pain Management Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Oral Veterinary Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Oral Veterinary Pain Management Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Oral Veterinary Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Oral Veterinary Pain Management Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Oral Veterinary Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Oral Veterinary Pain Management Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Oral Veterinary Pain Management Drugs Sales Value Share by Country, 2025 VS 2032
7 Oral Veterinary Pain Management Drugs Country-level Value Analysis
  1. 7.1 Global Oral Veterinary Pain Management Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Veterinary Pain Management Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Oral Veterinary Pain Management Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Oral Veterinary Pain Management Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Oral Veterinary Pain Management Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Oral Veterinary Pain Management Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Oral Veterinary Pain Management Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Oral Veterinary Pain Management Drugs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck & Co
  8. 8.2.1 Merck & Co Company Information
  9. 8.2.2 Merck & Co Business Overview
  10. 8.2.3 Merck & Co Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co Oral Veterinary Pain Management Drugs Product Portfolio
  12. 8.2.5 Merck & Co Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Oral Veterinary Pain Management Drugs Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Lilly
  20. 8.4.1 Lilly Company Information
  21. 8.4.2 Lilly Business Overview
  22. 8.4.3 Lilly Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lilly Oral Veterinary Pain Management Drugs Product Portfolio
  24. 8.4.5 Lilly Recent Developments
  25. 8.5 Bayer Pharma AG
  26. 8.5.1 Bayer Pharma AG Company Information
  27. 8.5.2 Bayer Pharma AG Business Overview
  28. 8.5.3 Bayer Pharma AG Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Pharma AG Oral Veterinary Pain Management Drugs Product Portfolio
  30. 8.5.5 Bayer Pharma AG Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Oral Veterinary Pain Management Drugs Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Norbrook Laboratories
  38. 8.7.1 Norbrook Laboratories Company Information
  39. 8.7.2 Norbrook Laboratories Business Overview
  40. 8.7.3 Norbrook Laboratories Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Norbrook Laboratories Oral Veterinary Pain Management Drugs Product Portfolio
  42. 8.7.5 Norbrook Laboratories Recent Developments
  43. 8.8 Halyard
  44. 8.8.1 Halyard Company Information
  45. 8.8.2 Halyard Business Overview
  46. 8.8.3 Halyard Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Halyard Oral Veterinary Pain Management Drugs Product Portfolio
  48. 8.8.5 Halyard Recent Developments
  49. 8.9 Forest Laboratories
  50. 8.9.1 Forest Laboratories Company Information
  51. 8.9.2 Forest Laboratories Business Overview
  52. 8.9.3 Forest Laboratories Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Forest Laboratories Oral Veterinary Pain Management Drugs Product Portfolio
  54. 8.9.5 Forest Laboratories Recent Developments
  55. 8.10 Endo International
  56. 8.10.1 Endo International Company Information
  57. 8.10.2 Endo International Business Overview
  58. 8.10.3 Endo International Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Endo International Oral Veterinary Pain Management Drugs Product Portfolio
  60. 8.10.5 Endo International Recent Developments
  61. 8.11 Elanco
  62. 8.11.1 Elanco Company Information
  63. 8.11.2 Elanco Business Overview
  64. 8.11.3 Elanco Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elanco Oral Veterinary Pain Management Drugs Product Portfolio
  66. 8.11.5 Elanco Recent Developments
  67. 8.12 Ceva Sante Animale
  68. 8.12.1 Ceva Sante Animale Company Information
  69. 8.12.2 Ceva Sante Animale Business Overview
  70. 8.12.3 Ceva Sante Animale Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ceva Sante Animale Oral Veterinary Pain Management Drugs Product Portfolio
  72. 8.12.5 Ceva Sante Animale Recent Developments
  73. 8.13 Bostonscientific
  74. 8.13.1 Bostonscientific Company Information
  75. 8.13.2 Bostonscientific Business Overview
  76. 8.13.3 Bostonscientific Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bostonscientific Oral Veterinary Pain Management Drugs Product Portfolio
  78. 8.13.5 Bostonscientific Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Oral Veterinary Pain Management Drugs Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research